Metastatic lung cancer is one of the most lethal forms of cancer and molecular pathways driving metastasis are still not clearly elucidated. Metastatic cancer cells undergo an epithelial-mesenchymal transition (EMT) where they lose their epithelial properties and acquire a migratory and invasive phenotype. Here we identify that the expression of microRNAs from the miR-200 family and the miR-183~96~182 cluster are significantly co-repressed in non-small cell lung cancer cell lines and primary tumors from multiple TCGA dataset with high EMT scores. Ectopic expression of the miR-183~96~182 cluster inhibited cancer cell migration and invasion, whereas its expression was tightly modulated by miR-200. We identified Foxf2 as a common, novel and direct target of both these microRNA families. Foxf2 expression tightly correlates with the transcription factor Zeb1 and is elevated in mesenchymal-like metastatic lung cancer cells. Foxf2 expression induced robust EMT, migration, invasion and metastasis in lung cancer cells, whereas Foxf2 inhibition significantly repressed these phenotypes. We also demonstrated that Foxf2 transcriptionally represses E-cadherin and miR-200, independent of Zeb1, to form a double-negative feedback loop. We, therefore, identified a novel mechanism whereby the miR-200 family and the miR-183~96~182 cluster inhibit lung cancer invasion and metastasis by targeting Foxf2. -9232/16 www.nature.com/onc Foxf2 induces EMT and metastasis in lung cancer ST Kundu et al Foxf2 induces EMT and metastasis in lung cancer ST Kundu et al
INTRODUCTION
Lung cancer is the leading cause of cancer-related deaths in the world, primarily because of aggressive metastatic progression. 1 The high mortality for this disease derives partly from limited therapeutic interventions and necessitates an understanding of the molecular pathways driving metastasis. One of the mechanisms contributing to metastasis in epithelial tumors is epithelialmesenchymal transition (EMT). During this process, a subset of cells from the primary tumor acquires invasive and migratory properties with the loss of epithelial cell polarity and intercellular adhesion. 2, 3 A series of transcription factors/repressors regulate EMT by inhibiting epithelial genes such as E-cadherin and miR-200 and inducing mesenchymal markers such as vimentin. The Zeb, Snail and Twist families of transcriptional repressors are the most well-documented EMT regulators in different cancers. [4] [5] [6] To elucidate the molecular mechanisms underlying EMT and metastasis, our laboratory has developed a syngeneic tumor model using cell lines isolated from a genetically engineered murine model with mutant Kras and p53 (KP mice). 7 Syngeneic tumors in this model vary in their metastatic potential. MicroRNA (miRNA) expression profiling revealed that the miRNA-200 family (miR-200) is repressed in the highly metastatic tumors and exogenous expression of miR-200 in the metastatic cells resulted in their inability to undergo EMT and metastasize. [8] [9] [10] miRNAs are 22 nucleotide non-coding RNAs that inhibit target genes by degrading the message or inhibiting translation. [11] [12] [13] [14] [15] Work from our lab and others has demonstrated that in many tumor types the miRNA-200 family (miR-200) modulates EMT by regulating the Zeb family of transcriptional repressors through a double-negative feedback loop. 9, [16] [17] [18] Recently, the miR--183~96~182 cluster was shown to be repressed by Zeb in p21-deficient colon cancer cells undergoing EMT and was significantly more invasive and migratory. 19 miR-183 has been shown to inhibit cancer cell migration and metastasis in breast 20 and bone 21 cancer cells, whereas it induced proliferative and migratory properties in soft tissue sarcomas 22 and medulloblastoma. 23 However, a role for the miR-183~96~182 cluster in lung cancer is not defined.
Forkhead-box (Fox) is a super family of transcriptional regulators that have myriad functions from development and proliferation to oncogenesis. Fox proteins have a conserved winged-helix DNAbinding domain and less conserved non-Fox domains, which mediate interactions with other transcriptional regulators for specific functions. 24, 25 The Foxf sub-family consists of two members, of which Foxf1 has been documented to induce EMT and invasion in breast cancers. 26 Foxf2 is required for gut development and promote extracellular matrix production 27 but little has been demonstrated on its role in cancer progression or metastasis. Here we provide evidence that the expression of miR-183~96~182 cluster is strongly correlated with miR-200 and EMT in non-small cell lung cancer (NSCLC) and multiple other epithelial tumor types. Both these miRNA families convergently target Foxf2, which can potently regulate EMT, invasion and metastasis in lung cancers by transcriptional repression of E-cadherin and miR-200.
RESULTS

Expression of miR-183~96~182 cluster is correlated with miR-200 and inhibits cell invasion
We generated miRNA expression profiles for 55 human NSCLC cell lines and applied a 76-gene EMT signature that we recently described to stratify into the epithelial-like and mesenchymal-like groups based on their gene expression pattern. 28, 29 In addition to the miR-200 family members, the miR-183~96~182 cluster was significantly repressed in the mesenchymal-like cells lines ( Figure 1a ). Like miR-200, the members of the miR-183~96~182 cluster also demonstrated significant negative correlation with the EMT scores 28 of samples from multiple TCGA data sets (Figure 1b and Supplementary Figures 1A and B ) representing a range of epithelial tumors, thus indicating that both miR-200 and miR-183~96~182 cluster are strongly associated with an epithelial state in different tumor types. In addition, the miR-183~96~182 cluster displayed significant positive correlation with miR-200 for all the tumor data sets (Supplementary Figure 1C ). The expression of the miR-183~96~182 cluster was validated by reverse transcription-quantitative PCR (qPCR) in both a panel of human NSCLC cell lines with varying miR-200 levels (Figure 1c and Supplementary Figure 1D ) and a panel of murine KP lung cancer lines where the miR-183~96~182 cluster expression was significantly lower in the metastatic mesenchymal cell lines (344SQ, 344LN, 531LN1 and 531LN2) with low miR-200 expression (as described previously 8, 9 ) than the epithelial non-metastatic cell lines (393LN, 412P, 307P and 393P) with low Zeb1 and high miR-200 8 (Figure 1d ). Exogenous Zeb1 expression in epithelial human HCC827 ( Supplementary Figures 1E and H) or murine 393P cell lines resulted in a significant repression of both the miR-200 family 8, 9 (Supplementary Figure 1H Figure 1g ). To test the functional role of miR-183~96~182 cluster on migration and invasion of NSCLC cells, human or mouse miR-96, miR-182 and miR-183 were transfected into mesenchymal human H157 ( Figure 1h ) or murine 344SQ cells (Figure 1j ), respectively, which significantly suppressed both migration and invasion (Figures 1i and k) . These results suggest that like miR-200, the expression of the miR-183~96~182 cluster is strongly associated with the epithelial state of cancer cells and directly regulates cancer cell migration and invasion.
Foxf2 is a novel and direct target of miR-96/182 and miR-200b/c with strong correlation with Zeb1 expression To investigate the mechanisms by which the mir-200 and the miR-183~96~182 cluster regulate EMT and subsequent cellular migration, invasion and metastasis in NSCLC, we searched for common predicted targets of these miRNA families. First, we performed a cross comparison of multiple gene expression data sets from our mouse models of metastasis. 9 We overlapped 224 genes that were elevated greater than fourfold upon Zeb1 induction in 393P cells, with 210 genes that showed greater than twofold increase in expression in the metastatic 344SQ cells compared with the non-metastatic 393P cells 9 and 143 genes that were repressed less than 0.5-fold in cells upon exogenous miR-200 expression 9 (Figure 2a ). This produced an enriched list of 45 genes that are potential miR-200 targets ( Supplementary Table 1 ). Next, we performed an overlap of genes predicted as targets of the miR-200 family (6032 genes) and the miR-183~96~182 cluster (2841 genes), using the miRNA prediction algorithm miRanda (www. microRNA.org) and identified a list of 17 highly conserved common targets (Supplementary Tables 2 and 3 ) with a mirSVR 30 score less than − 6.0 (Figure 2a ). The only two genes common in both the overlapping subsets were Zeb1 (ZFHX1A) and Foxf2. We also performed a gene set-enrichment analysis on the messenger RNA (mRNA) profiles from our murine metastatic 344SQ and nonmetastatic 393P tumors, 9 and Foxf2 was again identified in the list of most differentially expressed genes in the metastatic mesenchymal 344SQ tumors ( Supplementary Figure 2A ).
Foxf2 contains seed sequences for miR-200b/c/429, miR-96, miR-182 and miR-183 in its 3ʹ-untranslated region (UTR). Expression of miR-96, miR-182 and miR-183 resulted in significant repression of Foxf2 in both murine ( Figure 2b ) and human ( Figure 2c ) cells, along with specific downregulation of ADCY6 and JAZF1, which are two highly predicted targets of the miR-183~96~182 cluster, containing multiple target sequences in their 3ʹUTR's. 30, 31 Stable expression of the miR-200b~200a~429 cluster in 393P murine lung cancer cells significantly inhibited Foxf2 expression, whereas it was robustly induced when miR-200 was repressed by stable expression of Zeb1 8 (Figure 2d ). Similarly, a significant repression in FOXF2 expression was observed in human H157 cells (Figure 2e Figure 2B ). To ascertain whether Foxf2 is directly targeted by these miRNAs, we performed luciferase reporter assays with wild-type or miRNA-binding site mutant versions of the Foxf2-3ʹUTR. miR-200b/c significantly repressed luciferase activity of the Foxf2 wild-type 3ʹUTR construct, but not the version with a mutated miR-200b/c site ( Figure 2f ). Similarly, miR-96 significantly repressed luciferase activity from the WT 3ʹUTR, which was lost upon mutation of the recognition sites ( Figure 2g ). These results indicate that Foxf2 is a novel bona fide target of miR-200b, miR-200c and miR-96.
To further test whether Foxf2 expression is triggered by EMT, we treated murine or human lung cancer cells with transforming growth factor beta and observed a robust induction of Foxf2 (Supplementary Figure 2C) , which was comparable to the increase in Zeb1. 4, 17, [32] [33] [34] We also observed a strong correlation of Foxf2 with Zeb1 expression in our panel of KP mouse (Pearson 
Foxf2 induces EMT, invasion and metastasis
To examine the biological role of Foxf2 in lung cancer, green fluorescent protein (GFP)-tagged Foxf2 was exogenously expressed under a doxycycline-inducible promoter in the non-metastatic murine epithelial 393P cells. Foxf2 expression in 393P cells induced a marked cellular phenotypic change from a cobblestone, clustered, epithelial state to a fibroblastic, spindleshaped, scattered mesenchymal morphology, which reverted upon doxycycline withdrawal ( Figure 3a ). Control GFP-expressing cells showed no morphologic change (Supplementary Figure 3A) . This morphologic shift upon 10 days of Foxf2 expression was concordant with a significant induction of Zeb1 and marked E-cadherin repression both at the mRNA ( Figure 3b ) and protein ( Figure 3c ) levels, but with no significant change in the mesenchymal markers such as N-cadherin or vimentin. 393P-Foxf2(+) cells also exhibited robust increases in cellular migration and invasion in Boyden chambers compared with the control 393P-GFP(+) cells (Figure 3d and Supplementary Figure 3B ). To determine whether the phenotype produced by Foxf2 is cell line independent, GFP-tagged Foxf2 was inducibly expressed in epithelial murine (531P1) or human (HCC827) lung cancer cells. Foxf2 expression in both 531P1 and HCC827 cells induced an EMTlike morphologic change (data not shown and Supplementary Figure 3H Figure 3I ) but when grown in three-dimensional matrigel/collagen I cultures, were more invasive compared with the GFP control cells (Supplementary Figure 3K ). These results demonstrate that Foxf2 induces EMT, cellular migration and invasion in cells that are normally epithelial and non-invasive.
), with Zeb1 induction and E-cadherin suppression (Supplementary Figures 3C, D and J). 531P1-Foxf2 cells exhibited pronounced increases in migration and invasion compared with the GFP control cells (Supplementary Figures 3E and F). The HCC827-FOXF2 cells only demonstrated a modest increase of migration in Boyden chambers (Supplementary
To understand the potential role of Foxf2 during invasion and metastasis, we wanted to determine whether Foxf2 could modulate these biological functions in cells that are mesenchymal and have metastatic ability at baseline. For this, Foxf2 was inducibly expressed in the murine 344SQ cell line. As in the 393P and 531P1 cells, induction resulted in robust Foxf2 expression, nuclear localization of the protein and an EMT-like change in the cellular morphology when compared with the GFP-expressing cells (Figure 3e and Supplementary Figure 4A ). Molecularly, the 344SQ-Foxf2 cells exhibited a drastic suppression of E-cadherin, but mesenchymal markers were unchanged ( Figure 3f ). This observation was confirmed by immunofluorescence staining, which revealed a complete loss of E-cadherin from the cell membrane in the Foxf2-expressing cells compared with GFP (control) cells and resulted in re-localization of β-catenin from the cell surface into the cytoplasm (Supplementary Figure 4B) . The 344SQ-Foxf2 cells also exhibited a significant increase in cellular migration and invasion in Boyden chambers (Figure 3g and Supplementary Figure 3G ), but no difference in proliferation (Supplementary Figure 4C ). Growth in three-dimensional cultures revealed normal spheroid formation of the control 344SQ-GFP cells and remarkable invasive growth by the 344SQ-Foxf2 cells (Figure 3h ). To determine their in vivo metastatic potencies, 344SQ-Foxf2(+) or control 344SQ-GFP(+) induced cells were subcutaneously implanted into syngeneic mice. The primary tumor sizes for both the control and the Foxf2-expressing cells were comparable, consistent with no significant difference in cellular proliferation between the tumor types as evident from Ki-67 staining (Supplementary Figure 4D ). However, the mice with 344SQ-Foxf2 tumors demonstrated an approximately threefold increase in the number of metastatic lung nodules compared with Table 7 ). (c) qPCR analysis for relative expression of human ADCY6, JAZF1 or FOXF2 in H157 cells transfected with control miRNA precursor or precursors for human miR-96, miR-182 and miR-183 (Supplementary Table 7 ). and other EMT markers in 344SQ cells that are induced for 7 days for expression of either TRIPZ-GFP control vector (GFP(+)) or GFP-Foxf2 (Foxf2(+)) as indicated. (g) Trans-well migration or invasion of 344SQ cells induced for 7 days for expression of TRIPZ-GFP control vector (GFP(+)) or GFP-Foxf2 (Foxf2(+)) as indicated. (h) Left: bright-field microscopy of three-dimensional spheroids in different matrices as indicated, formed by 344SQ cells induced for 6 days for expression of TRIPZ-GFP control vector (344SQ-GFP(+)) or GFP-Foxf2 (344SQ-Foxf2(+)). Right: quantification of invasive structures formed by the respective cell lines in different matrices. (i) Left: quantification of tumor volumes of syngeneic mice injected with 344SQ cells induced for expression of TRIPZ-GFP control vector (GFP(+)) or GFP-Foxf2 (Foxf2(+)). Right: quantification of metastatic lung surface nodules formed in the mice injected with 344SQ cells induced for expression of either TRIPZ-GFP control vector (GFP (+)) or GFP-Foxf2 (Foxf2(+)). (j) Representative images of the haematoxylin and eosin sections of the lungs from mice injected with 344SQ cells induced for expression of TRIPZ-GFP control vector (344SQ-GFP(+)) or GFP-Foxf2 (344SQ-Foxf2(+)). Scale bar = 100 μM. (Significance is indicated by *P o0.05). the control cells (Figure 3i ) within just 4 weeks. This was confirmed by haematoxylin and eosin staining of the lung sections from each group (Figure 3j) . These results establish Foxf2 as a potent suppressor of the epithelial phenotype, which arrests cells in a hyper-invasive state, producing rapid in vivo metastasis.
Foxf2 knockdown suppresses invasion and metastasis
To study the converse effect, we stably knocked down Foxf2 expression in mesenchymal mouse and human cells by short hairpin RNA (shRNA) vectors. Foxf2 knockdown in mouse mesenchymal and metastatic 344SQ cells (344SQ-Foxf2-shE) did not result in an apparent change in cell morphology (data not shown), cell proliferation (Supplementary Figure 4C) or expression of the EMT markers (Figures 4a and b) , but significantly suppressed cellular migration and invasion in Boyden chambers (Figure 4c and Supplementary Figure 3L) . Similarly, in human H157 cells, knockdown of FOXF2 (H157-FOXF2-sh5) did not alter the expression of EMT genes (Figures 4d and e ) but produced significant inhibition of migration and invasion compared with vector controls (Figure 4f and Supplementary Figure 3M ). To test whether downregulation of Foxf2 expression could alter the in vivo metastatic potencies, the 344SQ-Foxf2-shE (knockdown) and the 344SQ-pGIPZ-NS (control) cells were injected subcutaneously in syngeneic mice. Both the groups formed comparablesized tumors at 8 weeks, with only a slight increase in proliferating cells in the primary tumors formed by the knockdown cells compared with the controls when assayed by Ki-67 staining (Figure 4g and Supplementary Figure 4D ). In contrast, the Foxf2 knockdown cells exhibited significant repression of lung metastasis (Figure 4g ), which was confirmed by haematoxylin-and eosin-stained lung sections (Figure 4h ). These results confirm that the inhibition of Foxf2 expression could significantly reduce the migratory and invasive capabilities of metastatic cells, abrogating in vivo metastasis. Interestingly by manipulating the levels of Foxf2 in the same (344SQ) cell line, we could control the metastatic phenotype of the cells, highlighting the importance of Foxf2 as a metastasis regulator.
Foxf2 induces rapid repression of E-cadherin and miR-200 independent of Zeb1
Foxf2 expression induces a strong EMT-like phenotype with increased migration, invasion and metastasis, which is associated with a robust inhibition of E-cadherin and upregulation of Zeb1.
To understand whether these two changes are a direct and acute consequence of Foxf2 expression, we performed a time-course assay to determine the changes in expression of these two markers upon induction of Foxf2 in 393P cells. Upon Foxf2 induction, E-cadherin was transcriptionally repressed as early as 4 h (50% at RNA level) and reached its maximum by 48 h (495% by mRNA and protein level (60%)), whereas Zeb1 protein levels were not considerably elevated (14%) until 48 h (Figures 5a and b ). Induction of GFP (control vector) did not induce any marked changes ( Supplementary Figures 5A and B) . As the miR-200 family is important regulator of the epithelial phenotype in lung cancer, 9 we examined whether they are regulated by Foxf2. We observed that mature miR-200a and miR-200b, but not miR-200c, were significantly repressed (70%) within 48 h of Foxf2 induction (Figure 5c ), whereas no significant changes were observed in the GFP vector cells (Supplementary Figure 5C ). This was confirmed by similar repression of the miR-429 levels (70%) within 72 h of Foxf2 induction, whereas miR-141 levels were unaltered (Supplementary Figure 5D) . These results suggest that Foxf2 might transcriptionally target only the miR--200b~200a~429 locus and not the miR-141~200c locus.
As the miR-200b~200a~429 cluster and E-cadherin are both known Zeb1 targets, 16, 35, 36 we sought to determine whether Foxf2-mediated repression of these two loci is dependent on Zeb1. Control small interfering RNA (siRNA) or siRNA targeting Zeb1 were transfected into control 393P-GFP or 393P-Foxf2 cells and both mRNA and protein were isolated at time points after Foxf2 or GFP induction. Both in the presence and the absence of Zeb1, E-cadherin was significantly repressed upon 48 h of Foxf2 induction, at the mRNA (450%; Figure 5d ) and protein (40%; Figure 5e ) levels. No change was observed in the 393-GFP vector cells (Supplementary Figure 5E ). To confirm these findings, we generated stable 393P cells with inducible Foxf2 and either scramble (control) hairpin (393P-Foxf2-sh-scramble) or shRNA hairpin targeting Zeb1 (393P-Foxf2-shZeb1), which showed 490% Zeb1 knockdown. Upon Foxf2 induction for 48 h, E-cadherin expression was significantly repressed both at RNA (50%) and protein (70%) levels in cells with endogenous Zeb1 expression. Similarly, in cells with stable knockdown of Zeb1, E-cadherin was significantly repressed both at RNA (50%) and protein (65%) levels after 48 h of Foxf2 induction ( Supplementary Figures 5G and H) . Figure 5F) . Similarly, quantitative PCR analysis for mature forms of mir-200a, mir-200b or mir-200c from 393P-Foxf2 (inducible) cells transfected with si-Control or si-Zeb1 revealed that they were significantly repressed upon Foxf2 induction, independent of Zeb1 status (Figure 5f ).
Induction of GFP did not change the levels of E-cadherin irrespective of Zeb1 status in the control cells (Supplementary
To determine whether E-cadherin and miR-200 repression are a result of direct inhibition of their promoter activities by Foxf2, we performed luciferase reporter assays using promoter constructs for E-cadherin and the miR-200b~200a~429 cluster. 16 We observed a significant repression of activity from both the promoters upon Foxf2 induction (Figure 5g ), which was independent of Zeb1, as demonstrated by the use of siRNA targeting Zeb1 versus control siRNA in 393P-GFP-(control) or 393P-Foxf2-inducible cells (Figure 5h ). To further assess direct binding of Foxf2 to the endogenous promoters of E-cadherin and miR-200b~200a~429, we performed chromatin immunoprecipitation assays with the 393P-GFP-(control) or 393P-Foxf2-inducible cells. We observed specific binding and enrichment for Foxf2 at different segments of the E-cadherin promoter (as indicated) and an unique segment~2500 bp upstream from the start site of the miR-200b precursor (Figure 5i ). All these enriched segments contain putative Foxf2-binding sites. Taken together, these results demonstrate that Foxf2 transcriptionally represses E-cadherin and miR-200b~200a~429 miRNA cluster, independent of Zeb1, to repress the epithelial phenotype and induce EMT, invasion and metastasis.
On the basis of our work here and the data in the literature, we propose a model in which the Zeb1-miR-200 axis works in concert with the miR-183-96-182 cluster to convergently target Foxf2 and regulate EMT, invasion and metastasis in lung cancer. In a Zeb1independent manner, Foxf2 represses E-cadherin and inhibits miR-200 to form a reinforcing negative feedback loop running in parallel with the Zeb1-miR-200 axis, to regulate invasion and metastasis ( Figure 5J ).
DISCUSSION
The molecular underpinnings driving lung cancer metastasis are largely unknown. There is a large body of evidence both in primary human tumors [37] [38] [39] and various mouse models of cancers, 9, [40] [41] [42] [43] which indicates EMT as a necessary and driving mechanism for metastasis of epithelial tumors. miRNAs are global regulators of gene expression and dysregulation of miRNAs and their signaling networks have been implicated in tumorigenesis and cancer metastasis. [44] [45] [46] [47] We and others have shown that deregulation of miR-200 by Zeb1 is critical to drive EMT and metastasis. 9, 17, 18, 48, 49 Metastasis is a complex biological process with compound stages of progression, 38,47 therefore, we hypothesized that multiple upstream molecular controllers are deregulated to coordinately control complementary cell functions necessary for initiation and progression of metastasis. We wanted to investigate other miRNAs such as miR-200 that act as upstream regulators of EMT and metastasis. By miRNA expression profiling, we identified that in addition to miR-200, the miR-183~96~182 cluster shows very strong negative correlation with EMT in a panel of 55 human NSCLC lines and intensive correlative studies in seven other primary tumor types from TCGA clinical specimens strongly reinforced this observation. This inclusive pan-cancer approach established with high confidence the functional association of the miR-183~96~182 cluster with EMT and metastasis.
miRNAs interact with different signaling molecules to produce varied and contrasting outcomes depending on the cell type and the microenvironment. 50, 51 Similarly, although anti-metastatic function of miR-183~96~182 was observed in certain cancers, [19] [20] [21] 52, 53 members of this cluster have demonstrated a pro-migratory and invasive role in other tumors. [54] [55] [56] [57] [58] [59] This suggests that miR-183~96~182 function is regulated contextually in a tissue-dependent manner. To specifically elucidate the molecular targets of miR-200 and miR-183~96~182, we performed a multistep cross comparison of gene expression profiles of the differently manipulated mouse model cells that overlapped with the list of high confidence common predicted targets of both the miRNA families. This approach gave us the unique advantage to utilize the extensive genomic data from our syngeneic mouse models to discover functionally relevant targets of miR-200 and the miR-183~96~182 cluster with a potential direct role in lung cancer metastasis. Foxf2 is a member of the forkhead box super family of transcriptional regulators that are known to function as oncogenes and tumor suppressors in divergent cancer types. 24, 25, 55, 60, 61 Other members of the Fox family, namely FOXM1 and FOXC1, have been reported as inducers of EMT, invasion and metastasis. 62, 63 Foxf1, the other member of the Foxf family has been reported to induce EMT, invasion and metastasis in breast and colorectal cancers. 26, 64 Foxf2 has been shown to be necessary for gut development and production of the extracellular matrix. 65, 66 Two recent reports also demonstrated the association of Foxf2 in a tumor suppressive role in breast 60 and prostate 55 cancers. Here we established that Foxf2 functions as a robust regulator of EMT, migration, invasion and metastasis in a syngeneic mouse lung cancer model with mutant Kras and p53. It has been reported that constitutive overexpression of Foxf2 from a transgenic allele in a mouse model for colorectal carcinogenesis resulted in decreased adenoma formation compared with wild-type or Foxf2 +/mice. 65 This suggests that specific genetic lesions in cancer regulate the activity of Foxf2 as a metastasis driver in a tissue-dependent context.
Multiple groups have convincingly defined the role of miR-200 as a master regulator of EMT and metastasis in different cancer types, 9, [67] [68] [69] with the double-negative feedback loop between Zeb1/2 and miR-200 as the best documented mechanism of miR-200 regulation. 9, 17, 18, 48, 49 The importance of this master regulator strongly suggests that there should be multiple layers of control over miR-200 expression. Additional transcription factors and chromatin modifiers have been shown to regulate miR-200 transcription in cancers. [70] [71] [72] [73] [74] Our data elucidate a novel mechanism where Foxf2 transcriptionally represses E-cadherin and miR-200, independent of Zeb1 to repress epithelial phenotype. We also identified a novel double-negative feedback loop between Foxf2 and miR-200, thus revealing a parallel axis to the Zeb1-miR-200 loop that controls EMT and metastasis. E-cadherin and miR-200 loss are nodal events in the onset and progression of EMT and metastasis and independent control in modulating these genes implies a pivotal role for Foxf2 as a parallel regulator of EMT and metastasis. In our miRNA expression profiles on the NSCLC lines, we also identified miR-205 and miR-203 that exhibited robust correlation with miR-200 and EMT, and further investigation of the functional targets of these miRNAs might reveal new interesting leads into the regulation of metastasis in lung cancers. 16 transfected in 393P cells that were induced for expression of either TRIPZ-GFP control vector (Vec(+)) or GFP-Foxf2 (Foxf2(+)) as indicated. (h) Top: relative normalized luciferase activities from reporter constructs pGL3, Cdh1-Pr-FL and miR-200-Pr-321, 16 transfected in 393P vector control or Foxf2 cells that were pre-transfected with control siRNA (si-Control) or siRNA targeting Zeb1 (si-Zeb1). Bottom: western blot analysis demonstrating efficient knockdown of Zeb1 and Foxf2 induction in 393P vector control or Foxf2 cells that were transfected with control siRNA (si-Control) or siRNA targeting Zeb1 (si-Zeb1), which were used in the experiment. (i) Fold enrichment of promoter segments as indicated, of E-cadherin and miR-200b~200a~429 promoters after chromatin immunoprecipitation assays performed in 393P-GFP (vector) or 393P-GFP-Foxf2 cells, using either an anti-GFP antibody or a mock IgG control antibody. (j) Model representing Foxf2 as a target of miR-200 and miR-183~96~182 cluster, which transcriptionally represses miR-200 and E-cadherin to induce cancer cell invasion and metastasis.
MATERIALS AND METHODS
Plasmids and reagents
Mouse or human Foxf2 complementary DNA was amplified by reverse transcription-PCR as a MfeI/EcoRI-MluI fragment (primers P1-P4, Supplementary Table 4 ) and cloned in the dox-inducible pTRIPZ-GFP vector where the miR-30~RFP cassette was replaced with the GFP complementary DNA. Mouse Foxf2 shRNA (pGIPZ-Foxf2-shE) construct was purchased from Open Biosystems/GE Dharmacon, Lafayette, CO, USA (Cat#RMM4431-200375685/CloneID#V3LMM_518867). Human FOXF2 shRNA (pLKO-FOXF2-sh5) construct was cloned in pLKO vector (Addgene, Cambridge, MA, USA) by ligating annealed oligos (P13, P14; Supplementary  Table 4 ). Reporter construct for Foxf2-3ʹUTR was generated by reverse transcription-PCR amplification of 0.7 kb 3ʹUTR of Foxf2 mRNA using specific primers (P5, P6; Supplementary Table 4 ) and cloned in pGL3-Promoter vector (Promega, Madison, WI, USA). miR-200-and miR-96/182binding site mutants of the Foxf2-3ʹUTR reporter construct were generated using specific primers (P7-P10; Supplementary Table 4 ) and QuickChange Lightning Site-Directed Mutagenesis Kit (Agilent, Santa Clara, CA, USA). Reporter construct for E-cadherin promoter was generated by PCR amplification of 1.6 kb promoter region of mouse E-cadherin using specific primers (P11, P12; Supplementary 
Reporter assays
For 3'-UTR reporter assays cells were co-transfected with 500 ng of the reporter construct and 50 nM miRNA precursors for 24 h and then assayed for luciferase activity after 24 h of doxycycline induction. For promoterreporter assays, cells were first pre-transfected for 72 h with siRNA followed by transfection for 24 h with 500 ng of the reporter constructs, then assayed for luciferase activity after 24 h of doxycycline induction. All reporter assays were performed using the Dual-Luciferase reporter assay system (Promega).
qPCR and western blot analysis
Total RNA was isolated and reverse transcription-PCR was performed using specific primers ( Supplementary Table 4 ) and SYBR Green PCR Master Mix (Life technologies). SYBR green qPCR analyses were normalized to expression of L32 (60 S ribosomal gene). Taq-man assays (Life technologies; Supplementary Table 5 ) for miRNA qPCR analyses were normalized to miR-16. Western blots were performed with antibodies as listed (Supplementary Table 5 ).
Analysis of miRNA expression and EMT using TCGA pan-cancer data
Level 3 TCGA pan-cancer data were used including gene expression (RNAseq) and miRNA expression (RNAseq). 75, 76 A summary of the samples with matched gene expression and miRNA data was provided in Supplementary Table 6 . EMT score was calculated from gene expression data using the EMT signature previously published. 28 Pearson correlation (r-value) was used to quantify the association between miRNA and EMT score.
Analysis of miRNA expression with EMT using human NSCLC cell lines
Affymetrix microRNA 4.0 samples were processed by Affymetrix Expression Console. Same cell line expression levels were averaged for each probe set.
EMT score was calculated from expression data profiled on Illumina WG v3 (San Diego, CA, USA) (GSE32036). There were 55 cell lines with both miRNA expression and EMT score. Two sample t-tests were used to test the difference between epithelial-like and mesenchymal-like groups (E is defined as EMT score o0 and M otherwise). miRNAs selected at false discovery rate level of 0.05 were used for heat map.
Analysis of mRNA expression array from Zeb1-transfected cells
Samples were shipped to Asuragen (Austin, TX, USA) for processing and analysis on Affymetrix Mouse Expression Array 430A 2.0 chips as previously described. 9 Array data have been deposited into the Gene Expression Omnibus (GSE61395).
Migration and invasion assays
Trans-well migration (8 μM inserts; BD Biosciences, San Jose, CA, USA) and invasion (BD Biosciences; #354480) assays were performed for 6 h (human cells) and 16 h (mouse cells) using standard protocol. 9 Inserts were stained with crystal violet and migrated or invaded cells were analyzed and counted using ImageJ software (NIH, Bethesda, MD, USA).
Chromatin immunoprecipitation assays
Chromatin immunoprecipitation assay was performed as described earlier 8, 10 with the modification that cells were fixed first with 5 mM dimethyl 3,3′-dithiobispropionimidate. 2HCl (Pierce-Thermo scientific, Rockford, IL USA) and then with 1% formaldehyde. Immunoprecipitation was performed using anti-GFP antibody (Abcam, Cambridge, MA, USA; ab290) or mock IgG (Santa Cruz, Dallas, TX, USA). Promoter segment enrichment was analyzed by qPCR using primers P49-56 (Supplementary Table 4 ).
Three-dimensional culture assay
Cells were seeded in a matrix comprising of matrigel (BD Biosciences; #354230) or a mixture of matrigel and collagen (BD Biosciences; #354236) and incubated for 6 days with regular replenishment with complete media containing 2% matrigel until formation of spheroids. 9 Spheroids were imaged and analyzed using an inverted microscope.
In vivo tumor and metastasis experiments
All animal experiments were reviewed and approved by the Institutional Animal Care and Use Committee at The University of Texas MD Anderson Cancer Center. Cells were subcutaneously injected in the flanks of syngeneic 129/Sv mice of 8-10 weeks age and observed for tumor growth for a period of 4-8 weeks. Upon euthanasia, metastatic nodules on the surface of lung lobes were counted. Lung tissue was fixed in 10% formalin and then processed for sectioning followed by haematoxylin and eosin staining.
